Michael D. West - 11 Dec 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Chief Executive Officer, Director
Signature
/s/Michael D. West
Issuer symbol
SER
Transactions as of
11 Dec 2022
Net transactions value
-$638
Form type
4
Filing time
13 Dec 2022, 20:22:13 UTC
Previous filing
13 Sep 2022
Next filing
14 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock, $0.0001 par value Options Exercise $0 +3,125 +8.3% $0.000000 40,998 11 Dec 2022 Direct F1
transaction AGE Common Stock, $0.0001 par value Tax liability $638 -1,081 -2.6% $0.5900 39,917 11 Dec 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Restricted Stock Units Options Exercise $0 -3,125 -50% $0.000000 3,125 11 Dec 2022 Common Stock 3,125 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership.
F2 Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F3 Restricted Stock Units vested on December 11, 2022.